Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

(0.1)

Payment of debt issuance costs 8 (32.8) -

Proceeds from drawings under bank facility 8 1,300.0 -

Repayment of drawings under bank facility 8 (1,300.0) -

Proceeds from exercise of New River purchased

call option 141.8 -

Proceeds from issue of ordinary shares, net of

issue costs 877.3 -

Proceeds from exercise of share options 30.4 82.0

Proceeds from exercise of warrants 13.0 -

Payments to acquire shares by ESOT(1) (186.0) (92.0)

Repayment of finance lease obligations (4.3) (5.5)

Dividends paid (41.3) (32.4)

__________ __________

Net cash provided by/(used in) financing

activities 1,618.7 (48.0)

__________ __________

Net (decrease)/increase in cash and cash

equivalents (370.4) 462.5

Cash and cash equivalents at beginning of year 1,126.9 656.5

Effect of foreign currency translation 6.0 7.9

__________ __________

Cash and cash equivalents at end of year 762.5 1,126.9

__________ __________

(1) Employee Share Option Trust

1. General information Shire plc ("the Company") and its subsidiaries (collectively referred to as the "Group" or "Shire") develop and market products for specialty physicians. The Group focuses on four therapeutic areas: ADHD, gast
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn ... biotechnology company, Syngenta, are in the process of being ... The consolidated case is In Re: Syngenta AG MIR ... District Court for the District of Kansas. , Management ... been handed over to U.S. District Judge John W. ...
(Date:12/24/2014)... 2014 According to Ross Selinger, President of ... ITRA Global, the national office market continues to be strong, ... is evidenced by the third quarter’s surprising 3.9% GDP, unemployment ... energy costs have held inflation down and the Fed is ... housing market remaining soft. , This solid economic news is ...
(Date:12/24/2014)... 23, 2014 Pipette.com announces their ... followers can submit their #HolidayInTheLab pictures for a chance ... mates. , For those struggling to think of a ... Holiday in the Lab Contest provides the ideal holiday ... to send pictures of their chemistree, holiday sweaters, ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... sciences for 2004 and what impact will these have on the ... the land of biotech and pharmaceuticals, the answer could be: , ... cardiovascular side effects and the resultant scrutiny on the FDA for ... the way, the recent Pfizer debacle with Celebrex in the last ...
... Larry Landweber knows networks. The University of Wisconsin-Madison ... forge some of the early international channels of the Internet. ... and its all about finding the right applications to ... WTN from Washington, D.C., where he works for the ...
... competition soon. A coalition of research and metropolitan ... an incubator for start-up biotech companies. , ,The ... new companies in, said representatives of the Milwaukee Biomedical ... attract companies to the area. , ,Guy Mascari, director ...
Cached Biology Technology:The greatest life-science developments of 2004 2The greatest life-science developments of 2004 3The greatest life-science developments of 2004 4The greatest life-science developments of 2004 5The greatest life-science developments of 2004 6The greatest life-science developments of 2004 7Landweber on networks, open source, and NSF budget cuts 2Landweber on networks, open source, and NSF budget cuts 3Landweber on networks, open source, and NSF budget cuts 4Milwaukee research alliance sees need for incubator 2
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... NY - JDRF said today that it has recognized the ... accelerating the pace of science in understanding the autoimmune attack ... the severe complications of this chronic and life-threatening disease. ... are Dr. Jeffrey A. Bluestone, Director of the Diabetes Center ...
... it much harder to evade justice in future, thanks to an ... tiny tags just 30 microns* in diameter and invisible to ... cartridges. They then attach themselves to the hands or gloves of ... completely. Crucially, some of these ,nanotags, also remain on ...
... United States die every year from uncontrolled infections of ... pushing the boundaries of molecular science to find new ... measure of an immune system protein within 24 hours ... can predict survival in children, yielding a powerful tool ...
Cached Biology News:JDRF announces 2008 Scholar Award recipients 2JDRF announces 2008 Scholar Award recipients 3Guilt on their hands: tiny 'tags' could help to solve and deter gun crime 2Immune system protein accurate predictor of survival in pediatric septic shock 2Immune system protein accurate predictor of survival in pediatric septic shock 3
... Fixed clamp trays and universal trays ... Magnetic drive Shaking speed: ... 25 mm amplitude Clamps ... 2000 ml, including Fernbach flasks ...
... convenient, and efficient Denatured protein concentration following ... spin column to make handling easy. The ... which were electro-eluted in their Denatured condition. ... high binding capacity fo all pH values. ...
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
Biology Products: